Heat-shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: a randomised, double-blind phase II study.

Lazar, L

Heat-shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: a randomised, double-blind phase II study. [electronic resource] - Diabetes/metabolism research and reviews May 2007 - 286-91 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial

1520-7552

10.1002/dmrr.711 doi


Adolescent
C-Peptide--blood
Chaperonin 60
Child
Child, Preschool
Diabetes Mellitus, Type 1--blood
Dose-Response Relationship, Drug
Double-Blind Method
Drug Therapy, Combination
Female
Follow-Up Studies
Gastroenteritis--chemically induced
Glycated Hemoglobin--metabolism
Humans
Hypoglycemic Agents--adverse effects
Injections, Subcutaneous
Insulin--adverse effects
Male
Peptide Fragments
Peptides--administration & dosage
Treatment Outcome